| Year |
Citation |
Score |
| 2023 |
Ambrosini V, Caplin M, Castaño JP, Christ E, Denecke T, Deroose CM, Dromain C, Falconi M, Grozinsky-Glasberg S, Hicks RJ, Hofland J, Kjaer A, Knigge UP, Kos-Kudla B, Koumarianou A, et al. Use and perceived utility of [ F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022. Journal of Neuroendocrinology. e13359. PMID 38097193 DOI: 10.1111/jne.13359 |
0.317 |
|
| 2023 |
Lens G, Ahmadi Bidakhvidi N, Vandecaveye V, Grauwels S, Laenen A, Deckers W, Peeters R, Dresen RC, Dekervel J, Verslype C, Nackaerts K, Clement PM, Van Cutsem E, Koole M, Goffin K, ... ... Deroose CM, et al. Intra-individual qualitative and quantitative comparison of [Ga]Ga-DOTATATE PET/CT and PET/MRI. Therapeutic Advances in Medical Oncology. 15: 17588359231189133. PMID 37885461 DOI: 10.1177/17588359231189133 |
0.315 |
|
| 2023 |
Pasquier D, Bidaut L, Oprea-Lager DE, deSouza NM, Krug D, Collette L, Kunz W, Belkacemi Y, Bau MG, Caramella C, De Geus-Oei LF, De Caluwé A, Deroose C, Gheysens O, Herrmann K, et al. Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups. The Lancet. Oncology. 24: e331-e343. PMID 37541279 DOI: 10.1016/S1470-2045(23)00286-3 |
0.488 |
|
| 2022 |
Deleu AL, Laenen A, Decaluwé H, Weynand B, Dooms C, De Wever W, Jentjens S, Goffin K, Vansteenkiste J, Van Laere K, De Leyn P, Nackaerts K, Deroose CM. Value of [Ga]Ga-somatostatin receptor PET/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and review of the literature. Ejnmmi Research. 12: 28. PMID 35524900 DOI: 10.1186/s13550-022-00900-3 |
0.321 |
|
| 2020 |
Van Rompaey W, Gheysens O, Deroose CM, Verleden SE, Vanaudenaerde BM, Ceulemans LJ, Van Raemdonck DE, Neyrinck AP, Verleden GM, Vos R. DIAGNOSTIC YIELD OF 18F-FDG PET AFTER LUNG TRANSPLANTATION: A SINGLE-CENTER, RETROSPECTIVE COHORT STUDY. Transplantation. PMID 32941392 DOI: 10.1097/TP.0000000000003456 |
0.568 |
|
| 2020 |
Weerasekera A, Crabbé M, Tomé SO, Gsell W, Sima D, Casteels C, Dresselaers T, Deroose C, Van Huffel S, Rudolf Thal D, Van Damme P, Himmelreich U. Non-invasive characterization of amyotrophic lateral sclerosis in a hTDP-43 mouse model: A PET-MR study. Neuroimage. Clinical. 27: 102327. PMID 32653817 DOI: 10.1016/J.Nicl.2020.102327 |
0.34 |
|
| 2020 |
Medaer E, Verslype C, Van Cutsem E, Dekervel J, Clement PM, Nackaerts K, Laenen A, Gheysens O, Goffin K, Jentjens S, Van Laere K, Deroose CM. Influence of pretreatment with everolimus or sunitinib on the subacute hematotoxicity of Lu-DOTATATE PRRT. Acta Oncologica (Stockholm, Sweden). 1-8. PMID 32036716 DOI: 10.1080/0284186X.2020.1723161 |
0.482 |
|
| 2019 |
Reichel C, Deroose C, Van Laere K, Goffin K. An Extraordinary Case of Brown Fat Distribution. Clinical Nuclear Medicine. PMID 31833931 DOI: 10.1097/Rlu.0000000000002822 |
0.314 |
|
| 2019 |
Deconinck S, Tosco L, Merckx L, Gheysens O, Deroose CM, Baldewijns M, Weynand B, Laere KV, Oyen R, Poppel HV, Joniau S, Goffin KE. Anatomical mapping of lymph nodes in patients receiving salvage lymphadenectomy based on a positive 11C-choline positron emission tomography/computed tomography scan. Central European Journal of Urology. 72: 232-239. PMID 31720023 DOI: 10.5173/ceju.2019.1910 |
0.557 |
|
| 2019 |
Deroose CM, Gheysens O, Perez-Lopez R. PET or MRI to improve response evaluation in clinical trials? The Lancet. Oncology. 20: 1060-1062. PMID 31486372 DOI: 10.1016/S1470-2045(19)30465-6 |
0.531 |
|
| 2019 |
Tuyaerts S, Annibali D, Dam PV, Lapeire L, Leunen K, Trum H, Kasius J, Glaudemans A, Deroose C, Amant F. EP692 Fulvestrant in gynaecological cancers that are potentially hormone sensitive: the FUCHSia study International Journal of Gynecological Cancer. 29. DOI: 10.1136/Ijgc-2019-Esgo.746 |
0.377 |
|
| 2018 |
Neyrinck K, Breuls N, Holvoet B, Oosterlinck W, Wolfs E, Vanbilloen H, Gheysens O, Duelen R, Gsell W, Lambrichts I, Himmelreich U, Verfaillie CM, Sampaolesi M, Deroose CM. The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction. Theranostics. 8: 2799-2813. PMID 29774076 DOI: 10.7150/Thno.22980 |
0.576 |
|
| 2018 |
Van Weehaeghe D, Gheysens O, Vandecaveye V, Schöffski P, Van Laere K, Deroose CM. Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to F-FDG-PET/CT. Bmc Cancer. 18: 253. PMID 29506493 DOI: 10.1186/s12885-018-4154-7 |
0.545 |
|
| 2018 |
Decaluwé H, Moons J, Fieuws S, De Wever W, Deroose C, Stanzi A, Depypere L, Nackaerts K, Coolen J, Lambrecht M, Verbeken E, De Ruysscher D, Vansteenkiste J, Van Raemdonck D, De Leyn P, et al. Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography-computed tomography? European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association For Cardio-Thoracic Surgery. 54: 134-140. PMID 29447330 DOI: 10.1093/Ejcts/Ezy018 |
0.356 |
|
| 2017 |
De Coster L, Sciot R, Everaerts W, Gheysens O, Verscuren R, Deroose CM, Pans S, Van Laere K, Goffin KE. Fibrous dysplasia mimicking bone metastasis on (68)GA-PSMA PET/MRI. European Journal of Nuclear Medicine and Molecular Imaging. PMID 28488027 DOI: 10.1007/s00259-017-3712-6 |
0.526 |
|
| 2017 |
Tosco L, Joniau S, Witters M, Battaglia A, Cromphout L, Goffin K, Gheysens O, Deroose C, Oyen R, Van Laere K. Predictive factors of positive 68Ga-PSMA PET/CT in patients with PSA recurrence following radical prostatectomy European Urology Supplements. 16: e1667-e1669. DOI: 10.1016/S1569-9056(17)31008-4 |
0.597 |
|
| 2017 |
Decaluwe H, Moons J, De Wever W, Deroose C, Stanzi A, Depypere L, Nackaerts K, Coolen J, Lambrecht M, De Ruysscher D, Vansteenkiste J, Van Raemdonck D, De Leyn P, Dooms C. P1.13-007 Is Central Lung Tumor Location Really Predictive for Occult Mediastinal Nodal Disease in (Suspected) NSCLC Staged cN0 on PET-CT? Journal of Thoracic Oncology. 12: S2034. DOI: 10.1016/J.Jtho.2017.09.1014 |
0.357 |
|
| 2016 |
Holvoet B, De Waele L, Quattrocelli M, Gheysens O, Sampaolesi M, Verfaillie CM, Deroose CM. Increased Understanding of Stem Cell Behavior in Neurodegenerative and Neuromuscular Disorders by Use of Noninvasive Cell Imaging. Stem Cells International. 2016: 6235687. PMID 26997958 DOI: 10.1155/2016/6235687 |
0.486 |
|
| 2016 |
Gheysens O, Thielemans S, Morscio J, Boeckx N, Goffin KE, Deroose CM, Sagaert X, Wlodarska I, Verhoef G, Dierickx D, Tousseyn T. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy. Leukemia & Lymphoma. 57: 2382-8. PMID 26854937 DOI: 10.3109/10428194.2016.1140162 |
0.59 |
|
| 2016 |
Deroose CM, Van Weehaeghe D, Tousseyn T, Van Rompuy AS, Vanderschueren S, Blockmans D, Gheysens O. Diffuse 18F-FDG Muscle Uptake in Trichinella spiralis Infection. Clinical Nuclear Medicine. 41: 55-6. PMID 26252328 DOI: 10.1097/Rlu.0000000000000933 |
0.561 |
|
| 2016 |
Cromphout L, Tosco L, Everaerts W, Albersen M, Gheysens O, Deroose C, Van Laere K, Goffin K, Joniau S. 565 Probability of positive PET imaging with a [68Ga]-labelled PSMA ligand based on PSA value in patients with biochemical recurrent prostate cancer after radical prostatectomy European Urology Supplements. 15: e565. DOI: 10.1016/S1569-9056(16)60567-5 |
0.591 |
|
| 2016 |
Tosco L, Gheysens O, Deroose C, De Meerleer G, Haustermans K, Everaerts W, Cromphout L, Van Poppel H, Van Laere K, Joniau S, Goffin K. 564 The role of 68Ga-PSMA PET/CT in the diagnosis and therapeutic decision making of oligometastatic recurrence after radical prostatectomy European Urology Supplements. 15: e564. DOI: 10.1016/S1569-9056(16)60566-3 |
0.588 |
|
| 2016 |
Joye I, Debucquoy A, Wolthuis A, D'Hoore A, Van Cutsem E, Vandecaveye V, Sagaert X, Deroose C, Haustermans K. EP-1282: Does blood glucose level normalisation improve PET-based response prediction in rectal cancer? Radiotherapy and Oncology. 119: S602-S603. DOI: 10.1016/S0167-8140(16)32532-4 |
0.324 |
|
| 2015 |
Holvoet B, Quattrocelli M, Belderbos S, Pollaris L, Wolfs E, Gheysens O, Gijsbers R, Vanoirbeek J, Verfaillie CM, Sampaolesi M, Deroose CM. Sodium Iodide Symporter PET and BLI Noninvasively Reveal Mesoangioblast Survival in Dystrophic Mice. Stem Cell Reports. 5: 1183-95. PMID 26626179 DOI: 10.1016/J.Stemcr.2015.10.018 |
0.573 |
|
| 2015 |
Gheysens O, Postnov A, Deroose CM, Vandermeulen C, de Hoon J, Declercq R, Dennie J, Mixson L, De Lepeleire I, Van Laere K, Klimas M, Chakravarthy MV. Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CT. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1520-6. PMID 26229142 DOI: 10.2967/jnumed.115.159715 |
0.528 |
|
| 2015 |
Cleeren FW, Lecina J, Billaud E, Ahamed M, Holvoet B, Goffin K, Deroose C, Verbruggen A, Bormans G. Radiosynthesis and preclinical evaluation of new (AlF)-F-18-labelled Urea-based PSMA inhibitors for PET imaging of prostate cancer Journal of Labelled Compounds and Radiopharmaceuticals. 58. PMID 25997630 DOI: 10.1002/Jlcr.3302_2 |
0.397 |
|
| 2015 |
Caekebeke E, Deroose CM, Verhamme P, Coolen J, Gheysens O. Asymmetric pulmonary hypermetabolism on 18F-FDG PET/CT caused by pulmonary embolism. Clinical Nuclear Medicine. 40: 338-9. PMID 25608154 DOI: 10.1097/RLU.0000000000000679 |
0.566 |
|
| 2014 |
Joye I, Deroose CM, Vandecaveye V, Haustermans K. The role of diffusion-weighted MRI and (18)F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 113: 158-65. PMID 25483833 DOI: 10.1016/j.radonc.2014.11.026 |
0.344 |
|
| 2014 |
De Raedt N, Gheysens O, Nackaerts K, Dooms C, De Ruysscher D, Deroose CM. Small lesion, severe consequences. An intriguing ventilation-perfusion scintigraphy. American Journal of Respiratory and Critical Care Medicine. 190: e12-3. PMID 25127312 DOI: 10.1164/rccm.201309-1637IM |
0.445 |
|
| 2014 |
Schöffski P, Deroose CM, Gheysens O, Lips N, Slabbaert K, Vancleynenbreugel B, Moerman P, Peetermans WE. The more you look, the more you find: challenging results on FDG-PET CT in a patient with neurofibromatosis type I. Bmc Medical Imaging. 14: 19. PMID 24885974 DOI: 10.1186/1471-2342-14-19 |
0.575 |
|
| 2014 |
Wolfs E, Holvoet B, Gijsbers R, Casteels C, Roberts SJ, Struys T, Maris M, Ibrahimi A, Debyser Z, Van Laere K, Verfaillie CM, Deroose CM. Optimization of multimodal imaging of mesenchymal stem cells using the human sodium iodide symporter for PET and Cerenkov luminescence imaging. Plos One. 9: e94833. PMID 24747914 DOI: 10.1371/Journal.Pone.0094833 |
0.32 |
|
| 2014 |
Gheysens O, Deroose CM, Tousseyn T, Goffin K, Verhoef G, Dierickx D. Hodgkin lymphoma-associated paraneoplastic cerebellar degeneration on FDG-PET/CT. British Journal of Haematology. 164: 468. PMID 24460525 DOI: 10.1111/bjh.12619 |
0.572 |
|
| 2014 |
Michielsen K, Vergote I, Op de Beeck K, Amant F, Leunen K, Moerman P, Deroose C, Souverijns G, Dymarkowski S, De Keyzer F, Vandecaveye V. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. European Radiology. 24: 889-901. PMID 24322510 DOI: 10.1007/S00330-013-3083-8 |
0.392 |
|
| 2014 |
Botticella A, Defraene G, Nackaerts K, Deroose C, Coolen J, Nafteux P, Peeters S, Ruysscher DD. 1562Poptimal Definition Of Target Volumes In Lung-Sparing Pleural Radiotherapy For Malignant Pleural Mesothelioma (Mpm) Annals of Oncology. 25. DOI: 10.1093/Annonc/Mdu357.6 |
0.397 |
|
| 2014 |
Peeters S, Dooms C, Vansteenkiste JF, Decaluwe H, Leyn PD, Nackaerts K, Wever WD, Deroose C, Ruysscher DD. 1197Oselective Mediastinal Node Irradiation In Nsclc In The Imrt/Vmat Era: Added Value Of Ebus-Tbna-Mapping To Pet-Ct Annals of Oncology. 25. DOI: 10.1093/Annonc/Mdu348.3 |
0.418 |
|
| 2014 |
Dirix P, Deroose C, Nafteux P, Lerut T, Coolen J, De Hertogh G, Prenen H, Van Cutsem E, Haustermans J. PD-0129: FDG-PET/CT for prediction and assessment of pathological response to induction CRT for esophageal carcinoma Radiotherapy and Oncology. 111: S50. DOI: 10.1016/S0167-8140(15)30234-6 |
0.361 |
|
| 2014 |
Peeters S, Dooms C, Vansteenkiste J, Decaluwe H, De Leyn P, Nackaerts K, De Wever W, Deroose C, De Ruysscher D. OC-0064: Selective mediastinal node irradiation in NSCLC in the IMRT/VMAT era: added value of EBUS-TBNA-mapping to PET-CT Radiotherapy and Oncology. 111: S24. DOI: 10.1016/S0167-8140(15)30169-9 |
0.339 |
|
| 2013 |
Wolfs E, Struys T, Notelaers T, Roberts SJ, Sohni A, Bormans G, Van Laere K, Luyten FP, Gheysens O, Lambrichts I, Verfaillie CM, Deroose CM. 18F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacity. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 447-54. PMID 23353687 DOI: 10.2967/Jnumed.112.108316 |
0.539 |
|
| 2012 |
Deroose CM, Chitneni SK, Gijsbers R, Vermaelen P, Ibrahimi A, Balzarini J, Baekelandt V, Verbruggen A, Nuyts J, Debyser Z, Bormans GM, Mortelmans L. Preliminary validation of varicella zoster virus thymidine kinase as a novel reporter gene for PET. Nuclear Medicine and Biology. 39: 1266-74. PMID 22981986 DOI: 10.1016/J.Nucmedbio.2012.06.014 |
0.312 |
|
| 2012 |
Haustermans K, Van den Bergh L, Isebaert S, Oyen R, Joniau S, Lerut E, Deroose C. 312 MULTIMODALITY IMAGING FOR TUMOUR TARGETING IN PROSTATE CANCER Radiotherapy and Oncology. 102: S166. DOI: 10.1016/S0167-8140(12)70272-4 |
0.307 |
|
| 2011 |
Gheysens O, Chen IY, Rodriguez-Porcel M, Chan C, Rasooly J, Vaerenberg C, Paulmurugan R, Willmann JK, Deroose C, Wu J, Gambhir SS. Non-invasive bioluminescence imaging of myoblast-mediated hypoxia-inducible factor-1 alpha gene transfer. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 13: 1124-32. PMID 21267661 DOI: 10.1007/S11307-011-0471-9 |
0.654 |
|
| 2010 |
Lambrecht M, Deroose C, Roels S, Vandecaveye V, Penninckx F, Sagaert X, Van Cutsem E, De Keyzer F, Haustermans K. The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer Acta Oncologica. 49: 956-963. PMID 20586658 DOI: 10.3109/0284186X.2010.498439 |
0.399 |
|
| 2010 |
Gheysens O, Baete K, Deroose CM, Mottaghy FM. Paramediastinal inflammatory changes after chemoradiation detected on FDG PET-CT imaging. Clinical Nuclear Medicine. 35: 355-6. PMID 20395714 DOI: 10.1097/RLU.0b013e3181d626d4 |
0.588 |
|
| 2010 |
Sergeant G, Deroose C, Hertogh GD, Moons J, Coosemans W, Nafteux P, Cutsem EV, Haustermans K, Mortelmans L, Lerut T. Early metabolic response evaluation on PET-CT after a single cycle of chemotherapy in patients with cT3-4N0/+ oesophageal or GE-junction cancer subsequently treated by neoadjuvant chemoradiotherapy Journal of Clinical Oncology. 28. DOI: 10.1200/Jco.2010.28.15_Suppl.E14505 |
0.404 |
|
| 2010 |
Lambrecht M, Deroose C, Roels S, Mortelmans L, Penninckx F, Van Cutsem E, Haustermans K. 34 oral: The Role of 18FDG-PET -CT In Response Prediction Before, During and After Neoadjuvant Chemoradiotherapy for Rectal Cancer Radiotherapy and Oncology. 94: S13. DOI: 10.1016/S0167-8140(15)34453-4 |
0.4 |
|
| 2009 |
Nuyts J, Michel C, Brepoels L, De Ceuninck L, Deroose C, Goffin K, Mottaghy FM, Stroobants S, Riet JV, Verscuren R. Performance of MAP reconstruction for hot lesion detection in whole-body PET/CT: an evaluation with human and numerical observers. Ieee Transactions On Medical Imaging. 28: 67-73. PMID 19116189 DOI: 10.1109/Tmi.2008.927349 |
0.322 |
|
| 2009 |
Maes W, Deroose C, Reumers V, Krylyshkina O, Gijsbers R, Baekelandt V, Ceuppens J, Debyser Z, Gool SW. In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma Journal of Neuro-Oncology. 91: 127-139. PMID 18787761 DOI: 10.1007/S11060-008-9691-5 |
0.326 |
|
| 2009 |
De Waele A, Nafteux P, Nackaerts K, Deroose C. Détection unilatérale de graisse brune en [18F]-FDG TEP/TDM dans le suivi d’un mésothéliome pleural MéDecine NucléAire. 33: 674-676. DOI: 10.1016/J.Mednuc.2009.07.015 |
0.328 |
|
| 2008 |
Celen S, Deroose C, de Groot T, Chitneni SK, Gijsbers R, Debyser Z, Mortelmans L, Verbruggen A, Bormans G. Synthesis and evaluation of 18F- and 11C-labeled phenyl-galactopyranosides as potential probes for in vivo visualization of LacZ gene expression using positron emission tomography. Bioconjugate Chemistry. 19: 441-9. PMID 18179161 DOI: 10.1021/Bc700216D |
0.321 |
|
| 2008 |
Singh A, Massoud TF, Deroose C, Gambhir SS. Molecular imaging of reporter gene expression in prostate cancer: an overview. Seminars in Nuclear Medicine. 38: 9-19. PMID 18096460 DOI: 10.1053/J.Semnuclmed.2007.09.002 |
0.711 |
|
| 2007 |
Deroose CM, De A, Loening AM, Chow PL, Ray P, Chatziioannou AF, Gambhir SS. Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 295-303. PMID 17268028 |
0.776 |
|
| 2006 |
Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet (London, England). 367: 113-21. PMID 16413875 DOI: 10.1016/S0140-6736(05)67861-0 |
0.508 |
|
| 2004 |
Min JJ, Biswal S, Deroose C, Gambhir SS. Tetraphenylphosphonium as a novel molecular probe for imaging tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 45: 636-43. PMID 15073261 |
0.646 |
|
| Show low-probability matches. |